Analyst Recommendations

H.C. Wainwright analyst issues BUY recommendation for USIO on April 1, 2024 06:01AM ET. The previous analyst recommendation was Buy.USIO was trading at $1.7 at issue of the...

April 1, 2024   USIO 2.05%

H.C. Wainwright analyst issues NEUTRAL recommendation for LABP on April 1, 2024 06:16AM ET. LABP was trading at $21.48 at issue of the analyst recommendation.The overall analyst consensus...

April 1, 2024   USIO 2.05%

H.C. Wainwright analyst issues BUY recommendation for IMNN on April 1, 2024 06:15AM ET. The previous analyst recommendation was Buy.IMNN was trading at $1.64 at issue of the...

April 1, 2024   IMNN 1.45%

Ascendiant analyst issues BUY recommendation for PHUN on April 1, 2024 03:04AM ET. The previous analyst recommendation was Buy.PHUN was trading at $8.96 at issue of the analyst...

April 1, 2024   PHUN -2.17%

Ascendiant analyst issues BUY recommendation for BIOL on April 1, 2024 03:05AM ET. The previous analyst recommendation was Buy.BIOL was trading at $0.1898 at issue of the analyst...

April 1, 2024   PHUN -2.17%

Craig-Hallum analyst issues BUY recommendation for UGRO on March 28, 2024 09:05AM ET. The previous analyst recommendation was Buy.UGRO was trading at $1.3988 at issue of the analyst...

March 28, 2024   UGRO 29.71%

Oppenheimer analyst issues OUTPERFORM recommendation for CLRB on March 28, 2024 07:33AM ET. The previous analyst recommendation was Outperform.CLRB was trading at $3.635 at issue of the analyst...

March 28, 2024   CLRB -3.97%

UBS analyst issues BUY recommendation for ENGN on March 28, 2024 08:19AM ET. ENGN was trading at $17.24 at issue of the analyst recommendation.
Historical Analyst Recommendations
Latest 10 recommendations

March 28, 2024   ENGN -6.05%

H.C. Wainwright analyst issues BUY recommendation for BTM on March 26, 2024 06:36AM ET. The previous analyst recommendation was Buy.BTM was trading at $2.22 at issue of the...

March 26, 2024   BTM -5.41%

Oppenheimer analyst issues OUTPERFORM recommendation for SLE on March 19, 2024 10:35AM ET. The previous analyst recommendation was Outperform.SLE was trading at $1.791 at issue of the analyst...

March 19, 2024   SLE -3.75%